Cargando…

EGFR, but not COX-2, protein in resected pancreatic ductal adenocarcinoma is associated with poor survival

The effects of EGFR and COX-2 protein overexpression on clinical outcomes in pancreatic ductal adenocarcinoma (PDAC) patients remains unclear. Therefore, the aim of the present study was to evaluate the protein expression of epithelial growth factor receptor (EGFR) and cyclooxygenase-2 (COX-2) in tu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fagman, Johan Bourghardt, Ljungman, David, Falk, Peter, Iresjö, Britt-Marie, Engström, Cecilia, Naredi, Peter, Lundholm, Kent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507389/ https://www.ncbi.nlm.nih.gov/pubmed/31186753 http://dx.doi.org/10.3892/ol.2019.10224

Ejemplares similares

Fractional uptake of circulating tumor cells into liver-lung compartments during curative resection of periampullary cancer
por: Vilhav, Caroline, et al.
Publicado: (2018)

Reduced tumor growth in EP2 knockout mice is related to signaling pathways favoring an increased local anti-tumor immunity in the tumor stroma
por: Khan, Maria, et al.
Publicado: (2022)

High expression of p62/SQSTM1 predicts shorter survival for patients with pancreatic cancer
por: Philipson, Eva, et al.
Publicado: (2022)

Preoperative overnight parenteral nutrition (TPN) improves skeletal muscle protein metabolism indicated by microarray algorithm analyses in a randomized trial
por: Iresjö, Britt‐Marie, et al.
Publicado: (2016)

EGF receptor and COX-1/COX-2 enzyme proteins as related to corresponding mRNAs in human per-operative biopsies of colorectal cancer
por: Asting, Annika Gustafsson, et al.
Publicado: (2013)

Circulating Carnosine Dipeptidase 1 Associates with Weight Loss and Poor Prognosis in Gastrointestinal Cancer
por: Arner, Peter, et al.
Publicado: (2015)

Myosin heavy chain 2A and α-Actin expression in human and murine skeletal muscles at feeding; particularly amino acids
por: Iresjö, Britt-Marie, et al.
Publicado: (2012)

Liver-derived endocrine IGF-I is not critical for activation of skeletal muscle protein synthesis following oral feeding
por: Iresjö, Britt-Marie, et al.
Publicado: (2013)

Initiation of muscle protein synthesis was unrelated to simultaneously upregulated local production of IGF-1 by amino acids in non-proliferating L6 muscle cells
por: Iresjö, Britt-Marie, et al.
Publicado: (2022)

Parathyroid hormone related protein (PTHrP) in patients with pancreatic carcinoma and overt signs of disease progression and host tissue wasting
por: Iresjö, Britt-Marie, et al.
Publicado: (2023)

Coexpression of EGFR and CXCR4 Predicts Poor Prognosis in Resected Pancreatic Ductal Adenocarcinoma
por: Wu, Huanwen, et al.
Publicado: (2015)

Simultaneous targeting of 5-LOX-COX and EGFR blocks progression of pancreatic ductal adenocarcinoma
por: Rao, Chinthalapally V., et al.
Publicado: (2015)

Estrogen biosynthesis in cultured skeletal muscle cells (L6) induced by amino acids
por: Iresjö, Britt-Marie, et al.
Publicado: (2019)

A comprehensive review of pancreatic cancer and its therapeutic challenges
por: Jiang, Shan, et al.
Publicado: (2022)

Sp1 and COX2 expression is positively correlated with a poor prognosis in pancreatic ductal adenocarcinoma
por: Hang, Junjie, et al.
Publicado: (2016)

Long-Term Results Following Antibiotic Treatment of Acute Appendicitis in Adults
por: Lundholm, K., et al.
Publicado: (2017)

Pharmacokinetics of preoperative intraperitoneal 5-FU in patients with pancreatic ductal adenocarcinoma
por: Öman, Mikael, et al.
Publicado: (2021)

Protein phase separation and its role in tumorigenesis
por: Jiang, Shan, et al.
Publicado: (2020)

C-reactive protein identifies patients at risk of postpancreatectomy hemorrhage
por: Vilhav, C., et al.
Publicado: (2022)

Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile?
por: Buc, Emmanuel, et al.
Publicado: (2014)

Weak HIF-1alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma
por: Leppänen, Joni, et al.
Publicado: (2018)

Plasminogen Activator Inhibitor 1 as a Poor Prognostic Indicator in Resectable Pancreatic Ductal Adenocarcinoma
por: Liu, Wen-Jing, et al.
Publicado: (2018)

Neoadjuvant and Adjuvant Treatments for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: The Current Status of Pancreatic Ductal Adenocarcinoma Treatment in Japan
por: Ei, Shigenori, et al.
Publicado: (2023)

Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma
por: Ormanns, Steffen, et al.
Publicado: (2015)

Pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head with venous resection
por: Flis, Vojko, et al.
Publicado: (2016)

Contemporary management of borderline resectable pancreatic ductal adenocarcinoma
por: Lekka, Kyriaki, et al.
Publicado: (2019)

Contemporary Review of Borderline Resectable Pancreatic Ductal Adenocarcinoma
por: Bonds, Morgan, et al.
Publicado: (2019)

Untargeted metabolomics characterization of the resectable pancreatic ductal adenocarcinoma
por: Cao, Ying-Ying, et al.
Publicado: (2023)

High JAK2 Protein Expression Predicts a Poor Prognosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma
por: Song, Yang, et al.
Publicado: (2020)

Associations between ABO blood groups and pancreatic ductal adenocarcinoma: influence on resection status and survival
por: El Jellas, Khadija, et al.
Publicado: (2017)

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma
por: Saukkonen, Kapo, et al.
Publicado: (2015)

A prognostic Bayesian network that makes personalized predictions of poor prognostic outcome post resection of pancreatic ductal adenocarcinoma
por: Bradley, Alison, et al.
Publicado: (2019)

An Evaluation of Neoadjuvant Chemoradiotherapy for Patients with Resectable Pancreatic Ductal Adenocarcinoma
por: Jiang, Hui, et al.
Publicado: (2013)

Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma
por: Lohneis, Philipp, et al.
Publicado: (2018)

The borderline resectable and locally advanced pancreatic ductal adenocarcinoma: Definition
por: Soweid, Assaad M.
Publicado: (2017)

Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2019)

Prediction of early recurrence of pancreatic ductal adenocarcinoma after resection
por: Sugawara, Toshitaka, et al.
Publicado: (2021)

Deficiency of mature B cells does not alter the atherogenic response to castration in male mice
por: Wilhelmson, Anna S., et al.
Publicado: (2022)

COX-2 overexpression in resected pancreatic head adenocarcinomas correlates with favourable prognosis
por: Pomianowska, Ewa, et al.
Publicado: (2014)

Biomarkers as Predictors of Recurrence following Curative Resection for Pancreatic Ductal Adenocarcinoma: A Review
por: Osayi, Sylvester N., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_bcoskpdovo9p02pg7adbkvhjuf